seed
Stage
6
Investors
About
Sensible Bio develops a cell-based platform for the design and manufacturing of high-quality mRNA therapeutics and vaccines, aiming to overcome limitations in current mRNA production methods.
Explore Sensible Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.